Patent details

EN | LT

LT - USE OF FVIIa OR A TISSUE FACTOR AGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS

EN - USE OF FVIIa OR A TISSUE FACTOR AGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 38/36
		A61P 9/10

European patent
(11)	Number of the document	1200116
(13)	Kind of document	T
(96)	European patent application number	00943706.2
	Date of filing the European patent application	2000-07-14
(97)	Date of publication of the European application	2002-05-02
(45)	Date of publication and mention of the grant of the patent	2008-10-15
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/DK2000/000401
	Date	2000-07-14

PCT application publication
(87)	Number	WO 2001/005353
	Date	2001-01-25

Inventors
(72)	EZBAN, Mirella, DK PETERSEN, Lars, Christian, DK SIEGBAHN, Agneta, SE

Grantee
(73)	Novo Nordisk Health Care AG, Andreasstrasse 15, 8050 Zürich, CH

Title
(54)	USE OF FVIIa OR A TISSUE FACTOR AGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS
	USE OF FVIIa OR A TISSUE FACTOR AGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS